On July 15, HCA Healthcare rose 3.68% in pre-market trading, trading at approximately $377.00/share, with turnover of $152,100. The rebound follows the prior session's sharp decline of over 6% triggered by a downward revision to full-year adjusted diluted EPS guidance.

On the news front, the company disclosed preliminary Q2 revenue of approximately $20.23 billion, significantly exceeding the FactSet consensus estimate of $19.47 billion. Additionally, HCA recognized $400 million in net gains from Medicaid supplemental payment programs during the quarter, providing repair momentum for the battered share price. Despite the revenue beat, multiple Wall Street firms have recently cut price targets, with the FactSet average declining from approximately $546 at the start of the year to around $490.85, including Stephens lowering its target to $480 from $500 while maintaining an overweight rating.

Within the Health Care Facilities sector, the overall sector stabilized in pre-market trading. Among individual stocks, Acadia Healthcare up 1.07%, Tenet Healthcare up 0.9%, Universal Health up 0.53%, Encompass Health Corporation up 0%, Brookdale Senior Living up 0%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)